These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1400808)

  • 1. Determination of N-acetylator phenotype using caffeine as a probe compound: a comparison of high-performance liquid chromatography and capillary electrophoresis methods.
    Lloyd DK; Fried K; Wainer IW
    J Chromatogr; 1992 Jul; 578(2):283-91. PubMed ID: 1400808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylator phenotyping via analysis of four caffeine metabolites in human urine by micellar electrokinetic capillary chromatography with multiwavelength detection.
    Guo R; Thormann W
    Electrophoresis; 1993; 14(5-6):547-53. PubMed ID: 8354241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for hydroxylation and acetylation polymorphisms in man via simultaneous analysis of urinary metabolites of mephenytoin, dextromethorphan and caffeine by capillary electrophoretic procedures.
    Caslavska J; Hufschmid E; Theurillat R; Desiderio C; Wolfisberg H; Thormann W
    J Chromatogr B Biomed Appl; 1994 Jun; 656(1):219-31. PubMed ID: 7952033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of caffeine and its metabolites in urine by high-performance liquid chromatography and capillary electrophoresis.
    Rodopoulos N; Norman A
    Scand J Clin Lab Invest; 1994 Jul; 54(4):305-15. PubMed ID: 7939374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alternative test for acetylator phenotyping with caffeine.
    Tang BK; Kadar D; Kalow W
    Clin Pharmacol Ther; 1987 Nov; 42(5):509-13. PubMed ID: 3677540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPLC method for rapid determination of acetylator phenotype by measuring urinary caffeine metabolites.
    Klebovich I; Arvela P; Pelkonen O
    J Pharm Biomed Anal; 1993 Oct; 11(10):1017-21. PubMed ID: 8305582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylation phenotypes and biological variation in a French Caucasian population.
    Pontes ZB; Vincent-Viry M; Gueguen R; Galteau MM; Siest G
    Eur J Clin Chem Clin Biochem; 1993 Feb; 31(2):59-68. PubMed ID: 8467011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simplified and rapid test for acetylator phenotyping by use of the peak height ratio of two urinary caffeine metabolites.
    el-Yazigi A; Chaleby K; Martin CR
    Clin Chem; 1989 May; 35(5):848-51. PubMed ID: 2566399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of acetylator phenotype in Caucasians with caffeine.
    Hildebrand M; Seifert W
    Eur J Clin Pharmacol; 1989; 37(5):525-6. PubMed ID: 2598993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
    William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
    Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
    Vincent-Viry M; Pontes ZB; Gueguen R; Galteau MM; Siest G
    Genet Epidemiol; 1994; 11(2):115-29. PubMed ID: 8013893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple test for acetylator phenotype using caffeine.
    Grant DM; Tang BK; Kalow W
    Br J Clin Pharmacol; 1984 Apr; 17(4):459-64. PubMed ID: 6721992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine metabolism in a healthy Spanish population: N-acetylator phenotype and oxidation pathways.
    Carrillo JA; Benítez J
    Clin Pharmacol Ther; 1994 Mar; 55(3):293-304. PubMed ID: 8143395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of an ELISA for N-acetyltransferase-2 (NAT2) phenotyping.
    Wong P; Banerjee K; Massengill J; Nowell S; Lang N; Leyland-Jones B
    J Immunol Methods; 2001 May; 251(1-2):1-9. PubMed ID: 11292476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylator phenotypes of Saudi Arabians by a simplified caffeine metabolites test.
    el-Yazigi A; Chaleby K; Martin CR
    J Clin Pharmacol; 1989 Mar; 29(3):246-50. PubMed ID: 2723111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of caffeine and five of the major metabolites in urine by high-performance liquid chromatography/tandem mass spectrometry.
    Weimann A; Sabroe M; Poulsen HE
    J Mass Spectrom; 2005 Mar; 40(3):307-16. PubMed ID: 15685651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine as a metabolic probe: validation of its use for acetylator phenotyping.
    Tang BK; Kadar D; Qian L; Iriah J; Yip J; Kalow W
    Clin Pharmacol Ther; 1991 Jun; 49(6):648-57. PubMed ID: 2060254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities.
    McQuilkin SH; Nierenberg DW; Bresnick E
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):139-46. PubMed ID: 7742721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between slow acetylator status and spontaneous lupus erythematosus.
    Kumana CR; Chan MM; Wong KL; Wong RW; Kou M; Lauder IJ
    Clin Pharmacol Ther; 1990 Aug; 48(2):208-13. PubMed ID: 2379389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between metabolic phenotype of N-acetylation and bladder cancer.
    Cui X; Guo R; Xu Z; Wang B; Li C
    Chin Med J (Engl); 2000 Apr; 113(4):303-5. PubMed ID: 11775223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.